Quiman, S.A. de C.V. v. United States

42 Cont. Cas. Fed. 77,227, 39 Fed. Cl. 171, 1997 U.S. Claims LEXIS 229, 1997 WL 644757
CourtUnited States Court of Federal Claims
DecidedOctober 20, 1997
DocketNo. 92-442C
StatusPublished
Cited by8 cases

This text of 42 Cont. Cas. Fed. 77,227 (Quiman, S.A. de C.V. v. United States) is published on Counsel Stack Legal Research, covering United States Court of Federal Claims primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Quiman, S.A. de C.V. v. United States, 42 Cont. Cas. Fed. 77,227, 39 Fed. Cl. 171, 1997 U.S. Claims LEXIS 229, 1997 WL 644757 (uscfc 1997).

Opinion

OPINION

FUTEY, Judge.

This case is presently before this court following a trial on the merits. In this action, plaintiff is seeking compensation for an alleged breach of contract by defendant. In response, defendant contends that no enforceable contract exists between the United States and plaintiff. Further, even if an enforceable contract exists, defendant maintains that it committed no breach. In addition, even assuming that defendant breached an enforceable contract, defendant argues that plaintiff suffered no compensable damages as a result of such breach.

Factual Background

Plaintiff is a Mexican corporation with its principal office and primary place of business in Mexico. During the time period involved in the present action, plaintiff produced fetal bovine serum (FBS), which is extracted from the blood of livestock fetuses at slaughterhouses and is processed, or filtered, at special laboratories. In the United States, FBS often is used in tissue culture media for the production of livestock vaccines. It may be imported as either “raw” product, which is unfiltered, or as “finished” or “sterile” product, which has been filtered. The United States Department of Agriculture (USDA), Animal and Plant Health Inspection Service (APHIS), manages the export and import of FBS.

In early 1987, plaintiff notified APHIS of its intention to export FBS to the United States. At that time, FBS could be imported into the United States under any of three procedures: (1) the Safety Testing Program; (2) the Gamma Irradiation System; or (3) the Overseas Source Inspection Program (OSI Program). Plaintiff chose to conduct its exports pursuant to the OSI Program. Under the OSI Program, an overseas company whose facilities had been inspected and approved by APHIS could export FBS to United States importers holding valid import permits issued by APHIS. Such exports would not be subject to safety-testing or gamma-irradiation upon entry into the United States. The OSI Program also required that an exporter’s facilities be inspected and approved annually in order to maintain their eligibility to export FBS to the United States under the program. All costs associated with the inspections were to be paid in advance by the exporter, as specified in a cooperative agreement entered into between APHIS and the cooperator.

The parameters of the OSI Program, as well as the other authorized methods of importation of FBS, were set out in a veterinary services notice dated April 6, 1987(VSN), issued by APHIS. A sample cooperative agreement regarding the OSI Program was attached to the VSN. Sample cooperative agreements representative of those required for importation pursuant to the other two authorized methods of importation also were attached to the VSN.

On June 20, 1987, plaintiff’s president met with a representative of APHIS. During that meeting, plaintiffs president signed the cooperative agreement (Cooperative Agreement) that is the subject of this litigation. The text of the Cooperative Agreement was prepared by an employee or employees of defendant. Mr. Robert L. Buchanan, Acting Administrator, Veterinary Services, APHIS, signed the Cooperative Agreement on defendant’s behalf, on July 20,1987.

Under the Cooperative Agreement, defendant agreed to: (1) provide inspectors to inspect plaintiffs facilities in Mexico to determine whether the facilities met with USDA approval; and (2) make an annual accounting of funds provided by plaintiff to pay for the inspections. For its part, plaintiff promptly deposited $15,000 with the United States Treasury in order to defray APHIS’ inspection costs and submitted a list of slaughterhouses for inspection. The Cooperative Agreement also provided that either party could terminate the Cooperative Agreement with sixty days notice to the other party. In addition, defendant would be relieved of any [175]*175obligations under the Cooperative Agreement in the event that plaintiff failed to deposit the necessary funds.

After the Cooperative Agreement was entered into by plaintiff and defendant, Dr. Juan M. Menehaca, a USDA employee, inspected several of plaintiffs slaughterhouses in Mexico. These inspections began on July 21,1987. The purpose of the inspections was to determine whether plaintiffs slaughterhouses complied with USDA requirements for approved foreign sources collecting fetal bovine blood to be used in the manufacture of FBS under the OSI Program. As a result of these inspections, defendant approved three of plaintiffs slaughterhouses as sources and disapproved two others. With regard to the two disapproved slaughterhouses, Dr. Men-chaca advised plaintiff of corrective actions necessary for approval.

Dr. Menehaca inspected an additional slaughterhouse, Rastro Municipal de Toluca [Toluca], on October 21,1987. Dr. Menehaca disapproved the slaughterhouse as a source of fetal bovine blood and advised plaintiff of corrective actions necessary for approval. On December 1, 1987, Dr. Menehaca, accompanied by Dr. Eduardo Serrano, reinspected the slaughterhouse and approved it as a source.1 On August 17, 1988, Dr. Menehaca again inspected this slaughterhouse through the OSI Program.2 Dr. Menehaca disapproved the slaughterhouse as a source.

On February 11, 1988, Dr. Menehaca and Dr. Juan Lubroth, also a USDA employee, inspected plaintiffs laboratory for the processing of FBS. They did not approve plaintiffs laboratory and instead recommended actions that plaintiff could take to correct the identified deficiencies. On February 26, 1988, Dr. Menehaca and Dr. Lubroth reinspected plaintiffs laboratory. Following the reinspection, Dr. Menehaca and Dr. Lubroth approved plaintiffs laboratory as a processor of FBS for purposes of the OSI Program. On December 7,1989, Dr. Lubroth reinspected and approved plaintiffs laboratory.

During the above-referenced time period, several U.S. importers held valid import permits issued by defendant that listed plaintiff as their overseas source, or supplier, of FBS. Pursuant to these permits, the U.S. imports ers purchased and imported FBS from plaintiff between 1987 and 1989. The last of the import permits expired on October 28, 1989. It is undisputed that after October 28, 1989, no U.S. importer applied for or held a permit allowing it to import FBS from plaintiff. Nor did plaintiff ever apply for or hold an import permit allowing it to import FBS from Mexico into the United States.

According to testimony elicited at trial, termination of the OSI Program was discussed within APHIS as early as January 1990. With respect to the proposed termination of the OSI Program, R.L. Rissler, Assistant Director, Operational Support Staff, Veterinary Services, APHIS, sent a memorandum dated February 1,1990, to Billy G. Johnson, Associate Deputy Administrator, Veterinary Services, APHIS. The memorandum recommended cancellation of the OSI Program as an approved option for the importation of FBS. The memorandum stated, in relevant part:

[T]here are only three USDA, Food Safety and Inspection Service supervised slaughterhouses in Mexico at the present time and the [Foot-and-Mouth Disease] FMD-program will not be able to provide us with the necessary support to continue this effort because they are reorganizing. Dr. Lubroth will be assuming duties in other areas which will prevent him from making any inspections for us. Since it is obvious that we cannot effectively monitor these facilities, we recommend that this program be discontinued. We do not believe that canceling the program will cause any hardship to U.S.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Turner v. United States
Federal Claims, 2014
Peninsula Group Capital Corp. v. United States
93 Fed. Cl. 720 (Federal Claims, 2010)
RCS Enterprises v. United States
57 Fed. Cl. 590 (Federal Claims, 2003)
Brazos Electric Power Cooperative, Inc. v. United States
52 Fed. Cl. 121 (Federal Claims, 2002)
Coast Federal Bank, FSB v. United States
48 Fed. Cl. 402 (Federal Claims, 2000)
Energy Capital Corp. v. United States
47 Fed. Cl. 382 (Federal Claims, 2000)
Bluebonnet Sayings Bank v. United States
47 Fed. Cl. 156 (Federal Claims, 2000)

Cite This Page — Counsel Stack

Bluebook (online)
42 Cont. Cas. Fed. 77,227, 39 Fed. Cl. 171, 1997 U.S. Claims LEXIS 229, 1997 WL 644757, Counsel Stack Legal Research, https://law.counselstack.com/opinion/quiman-sa-de-cv-v-united-states-uscfc-1997.